Bristol-Myers Squibb
BMY
BMY
2,590 hedge funds and large institutions have $116B invested in Bristol-Myers Squibb in 2022 Q4 according to their latest regulatory filings, with 263 funds opening new positions, 1,003 increasing their positions, 962 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more capital invested
Capital invested by funds: $116B → $116B (+$69.3M)
1.73% less ownership
Funds ownership: 76.92% → 75.19% (-1.7%)
34% less funds holding in top 10
Funds holding in top 10: 113 → 75 (-38)
Holders
2,590
Holding in Top 10
75
Calls
$2.26B
Puts
$1.82B
Top Buyers
| 1 | +$420M | |
| 2 | +$282M | |
| 3 | +$261M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$219M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$206M |
Top Sellers
| 1 | -$1.76B | |
| 2 | -$776M | |
| 3 | -$629M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$429M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$364M |